![Jan Komtebedde](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jan Komtebedde
Chief Tech/Sci/R&D Officer at Corvia Medical, Inc.
Jan Komtebedde active positions
Companies | Position | Start | End |
---|---|---|---|
Corvia Medical, Inc.
![]() Corvia Medical, Inc. Medical SpecialtiesHealth Technology Corvia Medical, Inc. develops medical devices for the treatment of heart failure. It also offers transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction. The company was founded by David S. Celermajer and is headquartered in Tewksbury, MA. | Chief Tech/Sci/R&D Officer | - | - |
Career history of Jan Komtebedde
Former positions of Jan Komtebedde
Companies | Position | Start | End |
---|---|---|---|
ABBOTT LABORATORIES | Corporate Officer/Principal | - | - |
Ancora Heart, Inc.
![]() Ancora Heart, Inc. Investment ManagersFinance Ancora Heart, Inc. manufactures medical devices for the treatment of mitral valve regurgitation. It develops percutaneous cardiac procedures for mitral valve regurgitation. The company was founded in 2001 by Lewis C. Pell, Niel F. Starksen and Nathan B. Pliam and is headquartered in Santa Clara, CA. | Chief Tech/Sci/R&D Officer | - | - |
Heartport, Inc.
![]() Heartport, Inc. Medical SpecialtiesHealth Technology Heartport, Inc. develops systems and procedures for heart surgery. The company's technologies allow surgeons to perform a wide range of less invasive open-chest and minimally invasive heart operations, including stopped heart and beating heart procedures. Heartport was founded in 1991 and is headquartered in Redwood City, CA. | Chief Tech/Sci/R&D Officer | - | - |
UC Davis School of Medicine | Corporate Officer/Principal | - | - |
Evalve, Inc.
![]() Evalve, Inc. Medical SpecialtiesHealth Technology Evalve, Inc. designs, develops, manufactures and markets devices. It developed a proprietary system which enables percutaneous repair of cardiac valves. The firm's products reduces the risks, trauma, and costs associated with current open, arrested heart surgical options. The company was founded on June 9, 1999 and is headquartered in Menlo Park, CA. | Sales & Marketing | 30/06/2001 | - |
Training of Jan Komtebedde
University of Utrecht | Doctorate Degree |
Statistics
International
United States | 7 |
Netherlands | 2 |
Operational
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 2 |
Sales & Marketing | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 3 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
ABBOTT LABORATORIES | Health Technology |
Private companies | 4 |
---|---|
Evalve, Inc.
![]() Evalve, Inc. Medical SpecialtiesHealth Technology Evalve, Inc. designs, develops, manufactures and markets devices. It developed a proprietary system which enables percutaneous repair of cardiac valves. The firm's products reduces the risks, trauma, and costs associated with current open, arrested heart surgical options. The company was founded on June 9, 1999 and is headquartered in Menlo Park, CA. | Health Technology |
Heartport, Inc.
![]() Heartport, Inc. Medical SpecialtiesHealth Technology Heartport, Inc. develops systems and procedures for heart surgery. The company's technologies allow surgeons to perform a wide range of less invasive open-chest and minimally invasive heart operations, including stopped heart and beating heart procedures. Heartport was founded in 1991 and is headquartered in Redwood City, CA. | Health Technology |
Corvia Medical, Inc.
![]() Corvia Medical, Inc. Medical SpecialtiesHealth Technology Corvia Medical, Inc. develops medical devices for the treatment of heart failure. It also offers transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction. The company was founded by David S. Celermajer and is headquartered in Tewksbury, MA. | Health Technology |
Ancora Heart, Inc.
![]() Ancora Heart, Inc. Investment ManagersFinance Ancora Heart, Inc. manufactures medical devices for the treatment of mitral valve regurgitation. It develops percutaneous cardiac procedures for mitral valve regurgitation. The company was founded in 2001 by Lewis C. Pell, Niel F. Starksen and Nathan B. Pliam and is headquartered in Santa Clara, CA. | Finance |
- Stock Market
- Insiders
- Jan Komtebedde
- Experience